Does BLINATUMOMAB Cause Leukaemia recurrent? 39 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Leukaemia recurrent have been filed in association with BLINATUMOMAB (BLINCYTO). This represents 0.4% of all adverse event reports for BLINATUMOMAB.
39
Reports of Leukaemia recurrent with BLINATUMOMAB
0.4%
of all BLINATUMOMAB reports
6
Deaths
12
Hospitalizations
How Dangerous Is Leukaemia recurrent From BLINATUMOMAB?
Of the 39 reports, 6 (15.4%) resulted in death, 12 (30.8%) required hospitalization, and 4 (10.3%) were considered life-threatening.
Is Leukaemia recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BLINATUMOMAB. However, 39 reports have been filed with the FAERS database.
What Other Side Effects Does BLINATUMOMAB Cause?
Pyrexia (1,064)
Acute lymphocytic leukaemia recurrent (977)
Cytokine release syndrome (952)
Off label use (590)
Death (588)
Neurotoxicity (530)
Drug ineffective (345)
Headache (335)
Neutropenia (265)
Febrile neutropenia (262)
What Other Drugs Cause Leukaemia recurrent?
METHOTREXATE (169)
CYTARABINE (146)
IMATINIB (138)
CYCLOPHOSPHAMIDE (134)
FLUDARABINE (107)
VINCRISTINE (103)
DEXAMETHASONE (91)
VENETOCLAX (81)
TRETINOIN (75)
DASATINIB (70)
Which BLINATUMOMAB Alternatives Have Lower Leukaemia recurrent Risk?
BLINATUMOMAB vs BLONANSERIN
BLINATUMOMAB vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1
BLINATUMOMAB vs BOCEPREVIR
BLINATUMOMAB vs BOCOCIZUMAB
BLINATUMOMAB vs BONIVA